A Phase IIa Study of Anti-GM-CSF Antibody GSK3196165 in Subjects with Inflammatory Hand Osteoarthritis
Schett G, Bainbridge C, Berkowitz M, Davy K, Fernandes S, Griep E, Harrison S, Layton M, Nowak NA, Patel J, Rech J, Watts S, Tak PP (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Book Volume: 70
Authors with CRIS profile
Georg Schett
Lehrstuhl für Innere Medizin III
Hans Jürgen Rech
Department of Medicine 3 – Rheumatology and Immunology
Involved external institutions
GlaxoSmithKline plc. (GSK)
United Kingdom (GB)
Royal Derby Hospital
United Kingdom (GB)
Antonius Ziekenhuis Sneek
Netherlands (NL)
United Kingdom (GB)
Royal Derby Hospital
United Kingdom (GB)
Antonius Ziekenhuis Sneek
Netherlands (NL)
How to cite
APA:
Schett, G., Bainbridge, C., Berkowitz, M., Davy, K., Fernandes, S., Griep, E.,... Tak, P.-P. (2018). A Phase IIa Study of Anti-GM-CSF Antibody GSK3196165 in Subjects with Inflammatory Hand Osteoarthritis.
MLA:
Schett, Georg, et al. "A Phase IIa Study of Anti-GM-CSF Antibody GSK3196165 in Subjects with Inflammatory Hand Osteoarthritis." 2018.
BibTeX: Download